This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of pharmaceutical products, medical supplies, and healthcare equipment, such as insulin pens, auto-injectors, inhalers, and various medications. The contract has a ceiling value of $1,491.37 and a performance period through November 25, 2024. Dakota Drug, Inc. also holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to provide a comprehensive range of medical products to support U.S. Armed Forces medical operations. This award is an unrestricted, non-set-aside contract.
Generated 2/21/25, 9:40 AM